{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:53:32Z","timestamp":1648770812811},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arzneimittelforschung"],"DOI":"10.1055\/s-0031-1299834","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T08:54:56Z","timestamp":1343724896000},"page":"805-813","source":"Crossref","is-referenced-by-count":0,"title":["Development of New Vaccines against Meningococcal Disease"],"prefix":"10.1055","volume":"53","author":[{"given":"Michael","family":"Br\u00f6ker","sequence":"additional","affiliation":[{"name":"Chiron Vaccines"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2011,12,25]]},"container-title":["Arzneimittelforschung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0031-1299834.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T19:14:05Z","timestamp":1495480445000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0031-1299834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,25]]},"references-count":0,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2003,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0031-1299834","relation":{},"ISSN":["0004-4172","1616-7066"],"issn-type":[{"value":"0004-4172","type":"print"},{"value":"1616-7066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,25]]}}}